# Severe Palatal Myiasis in a Young Patient With Neurological and Physical Disabilities: A Case Report

**Authors:** Marcelo Santos Bahia, Yuri de Lima Medeiros, Luan Viana Faria, Alexandre Elias Trivellato, Cassio Edvard Sverzut

PMC · DOI: 10.1111/scd.70039 · 2025-05-06

## TL;DR

A 16-year-old girl with neurological impairments developed severe palatal myiasis, requiring multidisciplinary treatment and highlighting challenges in such vulnerable patients.

## Contribution

This case report presents a rare instance of severe palatal myiasis in a neurologically impaired pediatric patient and emphasizes the need for prompt multidisciplinary care.

## Key findings

- The patient presented with palatal myiasis, bacterial pneumonia, and dyspnea due to larval migration.
- Treatment included manual larval removal, intravenous antibiotics, and surgical debridement, leading to stabilization.
- The case underscores the complexity of managing myiasis in patients with disabilities and socioeconomic challenges.

## Abstract

Myiasis can be particularly debilitating in pediatric patients with neurological impairments, as communication challenges in expressing symptoms may delay diagnosis and appropriate treatment. We report a case of palatal myiasis in a young Latin American patient with neurological deficits.

A 16‐year‐old female with a history of severe meningitis, which resulted in neurological sequelae including spastic paralysis and epilepsy, presented with an oral lesion in the buccal cavity and episodes of fever. Upon admission, she was diagnosed with bacterial pneumonia, multiple foci of myiasis in the hard and soft palate, and dyspnea caused by larval migration to the oropharyngeal region. Larvae were manually removed, and the patient was treated with intravenous ceftriaxone, clindamycin, and ivermectin. Nitrofurazone paste was also applied topically. Four days later, surgical debridement was performed to remove necrotic mucosa from the palate. No further larvae were detected, and the patient's condition stabilized. The patient has been under follow‐up for 1 year.

Severe palatal myiasis is a rare condition that demands prompt diagnosis and a multidisciplinary approach. This case highlights the complexity of managing myiasis in patients with physical and cognitive disabilities, especially in unfavorable socioeconomic conditions.

## Linked entities

- **Chemicals:** ceftriaxone (PubChem CID 5479530), clindamycin (PubChem CID 446598), nitrofurazone (PubChem CID 5447130)
- **Diseases:** meningitis (MONDO:0021108), bacterial pneumonia (MONDO:0004652), epilepsy (MONDO:0005027)

## Full-text entities

- **Diseases:** bacterial pneumonia (MESH:D018410), necrotic (MESH:D009336), spastic paralysis (MESH:C538358), dyspnea (MESH:D004417), meningitis (MESH:D008580), epilepsy (MESH:D004827), neurological deficits (MESH:D009461), cognitive disabilities (MESH:D003072), fever (MESH:D005334), Neurological and Physical Disabilities (MESH:D059445), oral lesion (MESH:D009059), Myiasis (MESH:D009198), neurological impairments (MESH:D009422)
- **Chemicals:** ivermectin (MESH:D007559), clindamycin (MESH:D002981), Nitrofurazone (MESH:D009583), ceftriaxone (MESH:D002443)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Figures

3 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12053963/full.md

---
Source: https://tomesphere.com/paper/PMC12053963